cancer drug trials
Almost half of all cancer drug trials show bias and exaggeration
September 19, 2019Research and Development BMJ, Cancer, cancer drug trials
New research on clinical trials between 2014 and 2016 raise “serious concerns about low standards” as over the three year …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
